A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants
Clinical trial NCT07549750 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07549750
- Sponsor
- Helixon Biotechnology (Suzhou) Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-27
- Primary completion
- 2027-03-18
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.